Bob Kentridge 1995
S2 Psychopathology: Lecture 1.
Biological Models of Psychopathology.
Psychopathologies are, as their name suggests, expressed as
abnormalities in people's psychological processes and
consequently their behaviour. In the first half of this course you
will have learned about explanations and treatments for
pathological psychological conditions which are themselves based
in psychology. This approach rests on explanations that these
conditions are caused by factors like people's maladaptive
psychological reactions to events in their lives or abnormalities in
the way they perceive events or their inappropriate attributions
of responsibility for events. Much of the treatment of
psychopathology that takes place today rests on a quite different
form of explanation and treatment - biological models of
psychopathology. Here the kind of causes proposed are physical
not mental and treatments are directed at the body, not the mind,
using drugs, or, in extreme cases, surgery.
In this lecture I want to address two questions. First, 'why did the
biological approach arise and why is it so prevalent?' and second,
'what basis and evidence is there for biological explanations of
psychopathology?' In the course of dealing with the second question
we will cover a few basics of neuroscience.
What has motivated biological models of
psychopathology?
It is strange, in a way, that we should try to explain mental
phenomena physically. In these days of brain-imaging when we can see
changes in brain activity which correspond to changes in people's
thoughts and actions it is not so surprising, but these physical
explanations of mental phenomena have been around much longer than
that. (In fact, even now, unambiguous evidence for correlations
between changes in brain activity and specific psychological phenomena
is hard to find). Hippocrates in his Sacred Disease (from the fifth
century B.C.), for example, asserted that
"Men ought to
know that from the brain, and from the brain alone, arise our
pleasures, joys, laughter and jests, as well as our sorrows, pain,
grief, and tears, ... It is the brain which makes us mad or delirious
... These things that we suffer all come from the brain, including
madness."
Hippocrates originated the humoral theory of
the body - the theory that the body is composed of four fluids -
blood, phlegm, yellow bile and black bile. Imbalances between these
fluids cause both physical and mental disease. An excess of black
bile, for example, caused melancholia and could be treated by
appropriate medicines or changes in diet. Ancient Chinese
explanations of madness also involved imbalances between classes of
substances and forces - the yin and the yang which may be physically
caused and treated. Hippocrates humoral theories remained popular
into the middle ages although spiritual explanations in terms of
witchcraft and demonic possession gained much ground (these
explanations also sometimes allowed 'treatment' by physical
interventions such as trepanning even though not physically caused -
physical treatment of ailments with non-physical causes is still
around today).
In our terms none of these 'biological' theories seem
to have any evidential basis, yet they survived for long periods of
time. One explanation might be that they were intimately bound up
with explanations and treatments of physical ailments which had some
success. If psychopathology is regarded as mental illness (now you
can see why I have struggled to avoid using 'mental illness' in place
of 'psychopathology') then it is natural to employ the same sort of
people and procedures to deal with it that are used in treating
physical diseases. In fact some people regard biological models of
psychopathology as just being one extreme of the more general medical
model of psychopathology, also including psychological approaches,
with their sequences of identifying pathologies, the symptoms
associated with them, diagnosis, therapy and cure. This
'anti-psychiatry' standpoint runs the risk, however, of glamourising
psychopathology just as tuberculosis aroused romantic notions of
illness in the 19th century - both, however, can be very unpleasant
for their sufferers. One question we can ask then is whether our
current biological models of mental illness are supported by direct
evidence rather than being merely shadows of biological models and
treatments of physical illness.
Before considering the types of explanations and treatments offered by
biological models of psychopathology it is worth stressing one general
point. The existence of a physical effect on a psychological
condition does not imply a physical cause for that condition. For
example, just because a drug can alter the mood of a depressive it
does not follow that the person was depressed because of a chemical
imbalance rectified by the drug. In these lectures I want to be
careful to distinguish between treatment and causation. Sometimes
biological treatments are given assuming biological causes and
psychological treatments are excluded or become secondary. In other
cases we may accept that a problem has a psychological cause but a
biological treatment may be more practical or successful than
psychological or social intervention.
Biological explanations, evidence and mechanisms.
Biological explanations of psychopathologies are usually
couched in terms of some abnormality or damage to a part of the brain.
Psychological functions are held to depend on the normal operation of
specific brain systems. So, when one particular system cannot operate
normally the consequence is a psychological dysfunction.
Biological treatments also carry the assumption that some
part of the brain serves a particular psychological function. They do
not, however, assume a physical cause for psychopathology. A brain
system may, for example, become overactive as a result of
psychological causes. Either psychological or biological intervention
could return it to a more normal level of operation. In both cases we
need to understand how the psychological processes may be divided up
between parts of the brain and how these particular systems operate
physically.
Now let us consider whether contemporary work in neuroscience really
provides clearer evidence for localised physical bases of
psychological function than Hippocrates had for his humoral theory.
Anatomy.
It has been assumed for a long time that different parts of the
brain subserve different psychological functions. An early
example is Gall's science of phrenology - discerning
people's personalities by studying the shapes of their skull and,
by inference, the shapes of their brains. Gall did not really
have any good evidence for his maps of brain function, however,
systematic experiments on the psychological effects of brain
lesions in animals and on the effects of brain-damage in people
caused by accidents or strokes has since given us quite a detailed
picture of the specialised roles of at least some parts of the brain.
Unfortunately the functions we can attribute to these brain
regions are often far removed from the factors we may imagine to
lie behind psychopathology. Brain mapping is telling us a great
deal about the subdivision of the visual processes of perception
but not much about personality. There are, however, notable
exceptions - some parts of the brain have been linked to the
production of normal emotional responses to events in animals
and even to the recognition of status in social hierarchies
(amygdala). Other brain regions have been implicated in
modulating and switching between these affective responses
(prefrontal cortex). Clearly damage or dysfunction in either of
these areas (which are quite densely interconnected) might lead
to psychopathology.
Neurotransmitters.
Many biological models of psychopathology are not, however,
based on anatomical divisions of the brain, but on chemical ones.
In order to understand this we need to know a little about the
way in which the nerve cells (neurons) which make up the brain
interact.
The human brain is comprised of about 10 billion neurons, each of
which can transmit signals along its fibres as a wave of
electrochemical activity. It is, however, thought, that brain
functions rely on collective interactions of activity in many neurons.
The average neuron can interact with about 10 thousand other neurons.
These interactions are almost all entirely chemical in nature. The
end of the nerve fibres that carry outgoing signal from a neuron
contact parts of other neurons in structures called synapses. There
is a tiny gap between the two cells. When a signal (action potential)
travels down the first neuron and reaches the end of the fibre tiny
quantities of a special chemical called a neurotransmitter are
released which flow across the gap (synaptic cleft) to the second
(postsynaptic) neuron. There are sites on the second neuron which are
specialised to receive this neurotransmitter. When the
neurotransmitter locks onto one of these receptor sites a reversible
chemical change takes place which alters the electrical properties of
the second cell. If enough receptors are activated the second neuron
may generate its own electrochemical action potential. Once it has
released its neurotransmitter the first (presynaptic cell) cell will
reabsorb it so it does not remain in the synaptic cleft and continue
to stimulate the second cell. Transmitter which is not reabsorbed is
eventually broken down by enzymes.
Drugs effect the action of neurotransmitters by a number of
methods - these are the main ones:
- Mimicking transmitters and hence stimulating postsynaptic cells. These
are called agonists.
- Fitting into receptor sites on the postsynaptic cell but not
producing electrochemical changes and hence blocking those receptors
from responding to the real neurotransmitter. These are called
antagonists or blockers.
- Stimulating the presynaptic cell to release more neurotransmitter
for each action potential. These are called indirect agonists.
- Suppressing the re-uptake of transmitter and hence leaving more
of it in the synaptic cleft for longer. These are called reuptake
inhibitors.
- Inhibiting the enzymes that break-down transmitter which is not
reabsorbed. These are called mono-amine oxidase inhibitors or MAOIs.
The reason that different drugs may be used to treat specific
conditions is that there are many different types of neurotransmitters
used in the brain and different drugs act on them selectively. The
neurons which use some of these neurotransmitters are also often
anatomically localised - so one might even be able to modify the
effects of localised physical damage using drugs. A great deal of
work has gone into discovering whether particular neurotransmitters,
or anatomically localised pathways of neurons using particular
transmitters, have distinct psychological roles. Much of the work I
will discuss later in the course concerns the neurotransmitter
dopamine which has linked to the signalling of pleasure or reward, to
the initiation of actions and to feeding control in studies of animals
- cocaine and amphetamines are examples of some drugs which stimulate
dopamine systems.
Lines of Evidence.
We now know a little about how the brain works and so have
some idea about how it might fail. Neurons in particular brain
areas may be damaged or die, or they may fail to produce the
right amounts of particular neurotransmitters. How can we make
a connection between defects like this and psychopathologies?
One source of evidence is to examine the brains of sufferers
directly. Inevitably this must be done after they have dies.
Post-mortem examination can reveal differences in both the structure
of and amounts of neurotransmitters found in parts of normal
people and sufferer's brains. These studies are very difficult,
however, both because of the limited numbers of brains available
for one reason or another and because drug-treatment during a
patients lifetime can often mask any inherent abnormalities.
Some measurements are also possible when people are alive. The levels
of neurotransmitters in people's brains can be assessed indirectly by
measuring the amounts of the breakdown products of these transmitters
in their urine. Brain scanners can detect gross structural brain
damage (CAT, MRI) or changes in the activity of relatively large
regions of the brain (PET fMRI). The interpretation of data obtained
in these ways can be very difficult, however. In addition to the
spatial and temporal limitation on the resolution of brain scanners
there are problems in finding tasks which might clearly differentiate
psychological processes in patients and control subjects. In
metabolite studies there are the problems determining whether changes
in breakdown product levels imply over- or under-effectiveness of the
precursor transmitter in the brain.
If we have a theory about the causation of a psychopathology
which rest on a behaviourally measurable factor like the ability to
perceive reward correctly or the ability to suppress responses
then we are able to investigate these factors in animals. It is then
possible to discover whether particular brain areas or
neurotransmitter systems mediate this behaviour by selectively
damaging them.
If we believe a pathology has a physical cause which is not
acquired but is inherited then we can also look for evidence using
methods of behaviour genetics. Care must be taken, however, that
genetic causes are not attributed to conditions which might be due
to upbringing. For this reason studies simply looking for patterns
of illness in family trees can be difficult to interpret. Studies in
which the prevalence of disease is compared between ordinary
and identical twins or between twins reared together and apart
yield more conclusive evidence but the subjects are hard to find.
Finally, of course, we can simply assess the effectiveness of
treatments in patients. If treatments vary in their effectiveness
according to their potency in effecting a particular
neurotransmitter system we take this as evidence for the
involvement of that system in the pathology. It is not, however,
evidence of a causative role.
Sources.
Every abnormal psychology textbook I've looked at has a chapter giving
a historical introduction and a quick overview of neurons and synapses
- Davison and Neale (the recommended text) is fine, although there was
a little more history in Kendall and Hammen's 'Abnormal Psychology'.
Silverston, T. and Turner, P. (1978) Drug treatment in psychiatry,
second edition. London: RKP, goes into more detail about drug action
than the abnormal texts but does not assume too much background
knowledge (being written for medical students and doctors!). The
introduction to Luria, A.R. (1973) The working brain. London: Penguin
has more discussion of phrenology and its successors.